We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$169M
AUM Growth
-$4.66M
Cap. Flow
+$2.74M
Cap. Flow %
1.62%
Top 10 Hldgs %
73.61%
Holding
610
New
35
Increased
156
Reduced
72
Closed
36

Top Buys

Rank Stock Value
1
ANAB icon
AnaptysBio
ANAB
+$1.53M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$1.14M
3
AXGN icon
Axogen
AXGN
+$586K
4
TSLA icon
Tesla
TSLA
+$504K
5
PLRX icon
Pliant Therapeutics
PLRX
+$501K

Top Sells

Rank Stock Value
1
FNA
Paragon 28, Inc.
FNA
+$1.36M
2
NVDA icon
NVIDIA
NVDA
+$517K
3
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$409K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$252K
5
PYCR
Paycor HCM, Inc. Common Stock
PYCR
+$144K

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Financials 5.86%
3 Technology 3.53%
4 Industrials 1.51%
5 Consumer Discretionary 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAS icon
351
Hasbro
HAS
$13.2B
$5.96K ﹤0.01%
97
-18
-16% -$1.09K
FFNW
352
DELISTED
First Financial Northwest, Inc
FFNW
$5.93K ﹤0.01%
262
– –
ELME
353
Elme Communities
ELME
$143M
$5.84K ﹤0.01%
336
+4
+1% +$65
AZN icon
354
AstraZeneca
AZN
$263B
$5.82K ﹤0.01%
40
– –
BIDU icon
355
Baidu
BIDU
$37.7B
$5.8K ﹤0.01%
63
-14
-18% -$1.26K
SONY icon
356
Sony
SONY
$137B
$5.71K ﹤0.01%
225
-59
-21% -$1.36K
HCAT icon
357
Health Catalyst
HCAT
$154M
$5.66K ﹤0.01%
1,250
– –
SAP icon
358
SAP
SAP
$212B
$5.64K ﹤0.01%
21
-4
-16% -$1.09K
FESM icon
359
Fidelity Enhanced Small Cap Core ETF
FESM
$5.95B
$5.59K ﹤0.01%
190
+1
+0.5% +$32
HII icon
360
Huntington Ingalls Industries
HII
$12.9B
$5.51K ﹤0.01%
27
– –
PUK icon
361
Prudential
PUK
$37.6B
$5.42K ﹤0.01%
252
– –
WBD icon
362
Warner Bros
WBD
$65.9B
$5.37K ﹤0.01%
500
+28
+6% +$293
VRTX icon
363
Vertex Pharmaceuticals
VRTX
$121B
$5.33K ﹤0.01%
11
– –
PII icon
364
Polaris
PII
$3.82B
$5.32K ﹤0.01%
+130
New +$6.19K
TTC icon
365
Toro Company
TTC
$8.75B
$5.31K ﹤0.01%
73
-12
-14% -$949
BMRN icon
366
BioMarin Pharmaceuticals
BMRN
$11.6B
$5.3K ﹤0.01%
75
– –
LAD icon
367
Lithia Motors
LAD
$8.47B
$5.28K ﹤0.01%
18
-5
-22% -$1.7K
AAL icon
368
American Airlines Group
AAL
$10.1B
$5.28K ﹤0.01%
500
– –
ON icon
369
ON Semiconductor
ON
$31.8B
$5.25K ﹤0.01%
129
– –
PYPL icon
370
PayPal
PYPL
$48.9B
$5.22K ﹤0.01%
80
– –
FSTA icon
371
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
$5.11K ﹤0.01%
100
-11
-10% -$555
CRM icon
372
Salesforce
CRM
$151B
$5.1K ﹤0.01%
19
– –
RITM icon
373
Rithm Capital
RITM
$5.52B
$4.97K ﹤0.01%
434
+5
+1% +$58
INTC icon
374
Intel
INTC
$455B
$4.97K ﹤0.01%
+219
New +$4.79K
MTH icon
375
Meritage Homes
MTH
$4.58B
$4.96K ﹤0.01%
70
+38
+119% +$2.86K
13 14
15
16 17

Similar funds

IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return
HA
Hanover Advisors Seneca, South Carolina $246M AUM 12.74% 1-Year Est. Return

HighMark Wealth Management's Q1 2025 Portfolio in Review

As of Q1 2025, HighMark Wealth Management held 610 positions worth $169M, down 2.7% from $174M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

HighMark Wealth Management's Q1 2025 filing shows 35 new, 156 increased, 72 reduced and 36 closed positions. Its largest new stake was AnaptysBio: 92,000 shares worth $1.71M. The largest sale was Paragon 28, Inc., an estimated $1.36M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q1 2025 buy was AnaptysBio: 92,000 shares worth $1.71M.
  • HighMark Wealth Management added most to Centessa Pharmaceuticals in Q1 2025, an estimated $1.14M increase.
  • HighMark Wealth Management's biggest Q1 2025 reduction was Paragon 28, Inc., cutting an estimated $1.36M.
  • HighMark Wealth Management fully exited Paycor HCM, Inc. Common Stock in Q1 2025, selling an estimated $144K.
  • HighMark Wealth Management's ten largest holdings make up 74% of its $169M portfolio in Q1 2025.
  • HighMark Wealth Management opened 35 new positions and closed 36 in Q1 2025.
  • HighMark Wealth Management's portfolio value fell 2.7% quarter-over-quarter to $169M.

Based on HighMark Wealth Management's 13F filing for Q1 2025, filed 24 Apr 2025.